BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22465047)

  • 1. Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia.
    Cuatrecasas G; Alegre C; Fernandez-Solà J; Gonzalez MJ; Garcia-Fructuoso F; Poca-Dias V; Nadal A; Cuatrecasas G; Navarro F; Mera A; Lage M; Peinó R; Casanueva F; Liñan C; Sesmilo G; Coves MJ; Izquierdo JP; Alvarez I; Granados E; Puig-Domingo M
    Pain; 2012 Jul; 153(7):1382-1389. PubMed ID: 22465047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study.
    Cuatrecasas G; Riudavets C; Güell MA; Nadal A
    BMC Musculoskelet Disord; 2007 Nov; 8():119. PubMed ID: 18053120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
    Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia.
    Jones KD; Burckhardt CS; Deodhar AA; Perrin NA; Hanson GC; Bennett RM
    Arthritis Rheum; 2008 Feb; 58(2):612-22. PubMed ID: 18240245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study.
    Bennett RM; Kamin M; Karim R; Rosenthal N
    Am J Med; 2003 May; 114(7):537-45. PubMed ID: 12753877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.
    Bennett RM; Clark SC; Walczyk J
    Am J Med; 1998 Mar; 104(3):227-31. PubMed ID: 9552084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial.
    Braz AS; Morais LC; Paula AP; Diniz MF; Almeida RN
    Braz J Psychiatry; 2013 Mar; 35(1):21-8. PubMed ID: 23567596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
    Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
    J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
    J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
    Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
    Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Distler O; Eich W; Dokoupilova E; Dvorak Z; Fleck M; Gaubitz M; Hechler M; Jansen JP; Krause A; Bendszus M; Pache L; Reiter R; Müller-Ladner U
    Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial.
    Noppers I; Niesters M; Swartjes M; Bauer M; Aarts L; Geleijnse N; Mooren R; Dahan A; Sarton E
    Eur J Pain; 2011 Oct; 15(9):942-9. PubMed ID: 21482474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of growth hormone deficiency in severe fibromyalgia syndromes.
    Cuatrecasas G; Gonzalez MJ; Alegre C; Sesmilo G; Fernandez-Solà J; Casanueva FF; Garcia-Fructuoso F; Poca-Dias V; Izquierdo JP; Puig-Domingo M
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4331-7. PubMed ID: 20631018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia.
    Patkar AA; Masand PS; Krulewicz S; Mannelli P; Peindl K; Beebe KL; Jiang W
    Am J Med; 2007 May; 120(5):448-54. PubMed ID: 17466657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
    J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study.
    North JM; Hong KS; Rauck RL
    Pain Pract; 2016 Jul; 16(6):720-9. PubMed ID: 26059271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
    Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia.
    Spaeth M; Alegre C; Perrot S; Wang Y; Guinta DR; Alvarez-Horine S; Russell I;
    Arthritis Res Ther; 2013 Nov; 15(6):R185. PubMed ID: 24286114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.